Role of food intolerance and effect of protease inhibitor in patients with irritable bowel syndrome (IBS)

Trial Profile

Role of food intolerance and effect of protease inhibitor in patients with irritable bowel syndrome (IBS)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2013

At a glance

  • Drugs Camostat mesilate (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 10 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top